Atorvastatin Attenuates Vancomycin-Induced Nephrotoxicity via PPARα-Associated Regulation of SLC Transporters
Drug Design, Development and Therapy · 2026
DOI: 10.2147/dddt.s571916 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026. Verfasst von Kexin Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Affiliated Hospital of Dalian Medical University, Dalian, People's Republic of China. Hauptthemen laut MEDLINE: Atorvastatin, Vancomycin, Kidney, PPAR alpha. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The First Affiliated Hospital of Dalian Medical University, Dalian, People's Republic of China.
- Department of Pharmaceutics, Dalian Women and Children's Medical Group, Dalian, Liaoning, 116012, People's Republic of China.
ORCID-Profile: Yanna Zhu
Zitieren
APA
Lin, K., Li, T., Kong, X., Li, T., Zuo, Y., Dong, D., Yang, S., & Zhu, Y. (2026). Atorvastatin Attenuates Vancomycin-Induced Nephrotoxicity via PPARα-Associated Regulation of SLC Transporters. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s571916
Vancouver
Lin K, Li T, Kong X, Li T, Zuo Y, Dong D, et al. Atorvastatin Attenuates Vancomycin-Induced Nephrotoxicity via PPARα-Associated Regulation of SLC Transporters. Drug Design, Development and Therapy. 2026. doi:10.2147/dddt.s571916
BibTeX
@article{Lin2026,
author = {Lin, Kexin and Li, Tingyu and Kong, Xiaorui and Li, Tong and Zuo, Yawen and Dong, Deshi and Yang, Shilei and Zhu, Yanna},
title = {Atorvastatin Attenuates Vancomycin-Induced Nephrotoxicity via PPARα-Associated Regulation of SLC Transporters},
journal = {Drug Design, Development and Therapy},
year = {2026},
doi = {10.2147/dddt.s571916}
}
EUVIMED